CA2013166A1 - Suppression de la synthese et de la secretion de l'hormone parathyroide - Google Patents

Suppression de la synthese et de la secretion de l'hormone parathyroide

Info

Publication number
CA2013166A1
CA2013166A1 CA2013166A CA2013166A CA2013166A1 CA 2013166 A1 CA2013166 A1 CA 2013166A1 CA 2013166 A CA2013166 A CA 2013166A CA 2013166 A CA2013166 A CA 2013166A CA 2013166 A1 CA2013166 A1 CA 2013166A1
Authority
CA
Canada
Prior art keywords
secretion
suppression
parathyroid hormone
hormone synthesis
hyperparathyroidism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2013166A
Other languages
English (en)
Other versions
CA2013166C (fr
Inventor
Eduardo Slatopolsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2013166A1 publication Critical patent/CA2013166A1/fr
Application granted granted Critical
Publication of CA2013166C publication Critical patent/CA2013166C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002013166A 1989-03-28 1990-03-27 Suppression de la synthese et de la secretion de l'hormone parathyroide Expired - Lifetime CA2013166C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US329,606 1989-03-28
US07/329,606 US4948789A (en) 1989-03-28 1989-03-28 Suppression of parathyroid hormone synthesis and secretion

Publications (2)

Publication Number Publication Date
CA2013166A1 true CA2013166A1 (fr) 1990-09-28
CA2013166C CA2013166C (fr) 2001-01-02

Family

ID=23286199

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002013166A Expired - Lifetime CA2013166C (fr) 1989-03-28 1990-03-27 Suppression de la synthese et de la secretion de l'hormone parathyroide

Country Status (15)

Country Link
US (1) US4948789A (fr)
EP (1) EP0390114B1 (fr)
JP (1) JPH0686382B2 (fr)
KR (1) KR0153532B1 (fr)
AT (1) ATE111737T1 (fr)
AU (1) AU618506B2 (fr)
CA (1) CA2013166C (fr)
DE (1) DE69012620T2 (fr)
DK (1) DK0390114T3 (fr)
ES (1) ES2063852T3 (fr)
HK (1) HK66895A (fr)
HU (1) HU211597A9 (fr)
IE (1) IE64949B1 (fr)
IL (1) IL93896A (fr)
ZA (1) ZA902353B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9220272D0 (en) * 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
JP2004504295A (ja) * 2000-07-18 2004-02-12 ボーン　ケア　インターナショナル　インコーポレイテッド 安定化１α−ヒドロキシビタミンＤ
WO2002017911A1 (fr) * 2000-08-30 2002-03-07 Teijin Limited Inhibiteurs de la production de parathormone contenant des derives de vitamine d3
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
JPWO2003004036A1 (ja) * 2001-07-03 2004-10-21 中外製薬株式会社 二次性副甲状腺機能亢進症の治療用医薬組成物および二次性副甲状腺機能亢進症治療に伴う心血管系合併症の治療薬
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3577552D1 (de) * 1984-11-27 1990-06-13 Chugai Pharmaceutical Co Ltd Vitamin d-derivate und verfahren zu deren herstellung.
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease

Also Published As

Publication number Publication date
IE64949B1 (en) 1995-09-20
ATE111737T1 (de) 1994-10-15
JPH0686382B2 (ja) 1994-11-02
ZA902353B (en) 1990-12-28
AU618506B2 (en) 1991-12-19
EP0390114A2 (fr) 1990-10-03
KR0153532B1 (ko) 1998-11-16
IL93896A (en) 1994-10-21
KR900013965A (ko) 1990-10-22
DE69012620T2 (de) 1995-03-23
DK0390114T3 (da) 1994-10-17
AU5210690A (en) 1990-10-04
HK66895A (en) 1995-05-12
IE901083L (en) 1990-09-28
DE69012620D1 (de) 1994-10-27
CA2013166C (fr) 2001-01-02
US4948789A (en) 1990-08-14
JPH037231A (ja) 1991-01-14
ES2063852T3 (es) 1995-01-16
HU211597A9 (en) 1995-12-28
EP0390114A3 (fr) 1991-10-30
EP0390114B1 (fr) 1994-09-21

Similar Documents

Publication Publication Date Title
AU618506B2 (en) Suppression of parathyroid hormone synthesis and secretion
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
TW221293B (fr)
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
AU6930591A (en) Method for inhibiting aging
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
HU912649D0 (en) New tricyclic compounds production threreof and anti-microbic preparatives
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
EP0743308A3 (fr) Composé quinazoléine et composition contre les tumeurs le contenant comme composé actif
AU648606B2 (en) Novel heptamethyl indane compound
EP0186023A3 (fr) Dérivés d'acides biliaires, procédé pour leur préparation et compositions pharmaceutiques les contenant
HK10292A (en) Intermediates for agriculturally useful acrylic acid derivatives
AU654300B2 (en) 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation
GB8908700D0 (en) Compounds
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
HK47592A (en) Piperazine derivatives
PL314794A1 (en) Crystalline polymorphous form of (s,s,s)-n-(1-[2-carbocy-3-(n2-mezilolysilamino)propyl]-1-cyclopentylocabonyl)thyrosine
JPS5775949A (en) Lidocaine derivative and therapeutical composition containing same as effective ingredient
IE822853L (en) 1-piperazino carboxylates
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
GB2039739A (en) Medicament against glaucoma
HK47492A (en) Piperazine derivatives
HUT58471A (en) Herbicidal composition comprising (sulfamidosulfonyl)-urea derivatives as active ingredient and process for producing the active ingredients
EP0118867A3 (fr) 4,10-Dihydro-10-oxothiénobenzoxépines substituées, méthode pour leur préparation, intermédiaires et leur utilisation comme médicaments

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry